Drug Profile
Alpha-1PDX
Alternative Names: A1PDXLatest Information Update: 02 Feb 2001
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Developer Hedral Therapeutics; Nonindustrial source
- Class Antivirals
- Mechanism of Action Furin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cytomegalovirus infections; HIV infections; Measles
Most Recent Events
- 02 Feb 2001 Profile reviewed but no significant changes made
- 28 Jul 1998 No-Development-Reported for Cytomegalovirus infections in USA (Unknown route)
- 28 Jul 1998 No-Development-Reported for HIV infections treatment in USA (Unknown route)